Table 2 |
||||
|
Adverse events reported during the first and second rituximab or placebo infusions in patients with rheumatoid arthritis |
||||
|
First infusion |
Second infusion |
|||
|
|
|
|||
|
Adverse event |
Placebo |
Rituximab (1000 mg) |
Placebo |
Rituximab (1000 mg) |
|
|
||||
|
Any adverse event |
30 |
36 |
15 |
17 |
|
Transient hypotension |
20 |
13 |
10 |
12 |
|
Transient hypertension |
10 |
9 |
5 |
3 |
|
Flushing |
- |
4 |
- |
1 |
|
Pruritus |
- |
6 |
- |
- |
|
Rash |
- |
4 |
- |
- |
|
Dyspnoea |
- |
3 |
- |
- |
|
Pharynx discomfort |
- |
3 |
- |
- |
|
Pyrexia |
- |
3 |
- |
- |
|
Headache |
- |
2 |
- |
- |
|
|
||||
|
Hypotension/hypertension were defined as an increase/decrease in systolic or diastolic pressure of more than 30 mmHg. Values are expressed as percentages. Data from SzczepaĆski and coworkers [23]. |
||||
|
Hainsworth Arthritis Res Ther 2003 5(Suppl 4):S12 doi:10.1186/ar1008 |
||||